KR100192991B1 - 트리플루오로메틸케톤 유도체, 그것의 제법 및 용도 - Google Patents

트리플루오로메틸케톤 유도체, 그것의 제법 및 용도 Download PDF

Info

Publication number
KR100192991B1
KR100192991B1 KR1019910024710A KR910024710A KR100192991B1 KR 100192991 B1 KR100192991 B1 KR 100192991B1 KR 1019910024710 A KR1019910024710 A KR 1019910024710A KR 910024710 A KR910024710 A KR 910024710A KR 100192991 B1 KR100192991 B1 KR 100192991B1
Authority
KR
South Korea
Prior art keywords
amino
valyl
compound
alkyl
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019910024710A
Other languages
English (en)
Korean (ko)
Other versions
KR920011988A (ko
Inventor
게이지 헴미
이찌로 시마
게이수께 이마이
히로까쯔 다나까
Original Assignee
후지야마 아키라
후지사와 야꾸힝 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909028231A external-priority patent/GB9028231D0/en
Priority claimed from GB919119713A external-priority patent/GB9119713D0/en
Application filed by 후지야마 아키라, 후지사와 야꾸힝 고교 가부시키가이샤 filed Critical 후지야마 아키라
Publication of KR920011988A publication Critical patent/KR920011988A/ko
Application granted granted Critical
Publication of KR100192991B1 publication Critical patent/KR100192991B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Magnetically Actuated Valves (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
KR1019910024710A 1990-12-31 1991-12-27 트리플루오로메틸케톤 유도체, 그것의 제법 및 용도 Expired - Lifetime KR100192991B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9028231.0 1990-12-31
GB909028231A GB9028231D0 (en) 1990-12-31 1990-12-31 Trifluoromethylketone derivatives,processes for preparation thereof and use thereof
GB91197137 1991-09-16
GB919119713A GB9119713D0 (en) 1991-09-16 1991-09-16 Trifluoremethylketone derivatives, processes for preparation thereof and use thereof
GB9119713.7 1994-09-16

Publications (2)

Publication Number Publication Date
KR920011988A KR920011988A (ko) 1992-07-25
KR100192991B1 true KR100192991B1 (ko) 1999-06-15

Family

ID=26298196

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910024710A Expired - Lifetime KR100192991B1 (ko) 1990-12-31 1991-12-27 트리플루오로메틸케톤 유도체, 그것의 제법 및 용도

Country Status (19)

Country Link
US (2) US5296591A (enExample)
EP (1) EP0494071B1 (enExample)
JP (1) JPH0699378B2 (enExample)
KR (1) KR100192991B1 (enExample)
CN (1) CN1040003C (enExample)
AT (1) ATE151775T1 (enExample)
AU (1) AU641577B2 (enExample)
CA (1) CA2058560C (enExample)
DE (1) DE69218977T2 (enExample)
DK (1) DK0494071T3 (enExample)
ES (1) ES2099755T3 (enExample)
FI (1) FI106379B (enExample)
GR (1) GR3023719T3 (enExample)
HU (2) HU210263B (enExample)
IE (1) IE914360A1 (enExample)
MX (1) MX9102612A (enExample)
NO (1) NO309274B1 (enExample)
RU (1) RU2073684C1 (enExample)
SG (1) SG50457A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
FR2719589B1 (fr) * 1994-05-05 1996-06-14 Adir Nouveaux peptides dérivés de trifluorométhylcétones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
PT762887E (pt) * 1994-06-02 2002-01-30 Merrell Pharma Inc Derivados do enol acetilado como pro-farmacos de inibidores de elastase
EP0763055B1 (en) * 1994-06-02 1999-11-03 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
WO1999043352A1 (en) * 1998-02-24 1999-09-02 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
US20020045231A1 (en) * 1999-02-02 2002-04-18 Napper Andrew D. Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
KR20020050235A (ko) * 1999-10-12 2002-06-26 후지야마 아키라 난치성 창상의 치료제
IL148924A (en) * 2002-03-26 2015-06-30 Mor Research Applic Ltd Use of substances that inhibit intracellular elastase activity in the preparation of a drug for the treatment and / or prevention of necrosis of cells and related diseases
DE10219464A1 (de) 2002-04-30 2003-11-13 Focke & Co Zigarettenpackung
SE0202462D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab Novel use
KR101069089B1 (ko) * 2006-05-23 2011-09-30 아이알엠 엘엘씨 채널 활성화 프로테아제 억제제로서의 화합물 및 조성물
WO2008023446A1 (fr) * 2006-08-25 2008-02-28 Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. Remède pour des bronchopneumopathies chroniques obstructives
CN101534824A (zh) * 2006-11-17 2009-09-16 艾博特公司 作为化学活素受体拮抗剂的氨基吡咯烷
WO2011046954A1 (en) 2009-10-13 2011-04-21 Ligand Pharmaceuticals Inc. Hematopoietic growth factor mimetic small molecule compounds and their uses
ES2645847T3 (es) * 2013-05-08 2017-12-11 Kissei Pharmaceutical Co., Ltd. Derivado de glicinamida alfa-sustituido
CN104650016A (zh) * 2015-01-29 2015-05-27 武汉大学 拟三肽类化合物及其制备方法
EP4008304B1 (en) * 2016-06-24 2025-07-23 Pola Chemical Industries Inc. External preparation for skin for wrinkle improvement
MX2020004892A (es) 2017-11-15 2020-08-06 Pola Chem Ind Inc Composicion a base de aceite.
CN119241385B (zh) * 2024-11-29 2025-03-25 江西师范大学 β-酰氧基烯酰胺衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
EP0369391A3 (en) 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof

Also Published As

Publication number Publication date
CA2058560C (en) 2000-12-12
FI106379B (fi) 2001-01-31
ES2099755T3 (es) 1997-06-01
GR3023719T3 (en) 1997-09-30
ATE151775T1 (de) 1997-05-15
US5430025A (en) 1995-07-04
HUT60507A (en) 1992-09-28
MX9102612A (es) 1992-06-01
NO920035L (no) 1992-07-01
JPH0699378B2 (ja) 1994-12-07
CN1063108A (zh) 1992-07-29
NO920035D0 (no) 1992-01-02
CA2058560A1 (en) 1992-07-01
EP0494071A2 (en) 1992-07-08
DK0494071T3 (enExample) 1997-05-12
EP0494071B1 (en) 1997-04-16
HU210263B (en) 1995-03-28
AU641577B2 (en) 1993-09-23
FI915996L (fi) 1992-07-01
IE914360A1 (en) 1992-07-01
DE69218977D1 (de) 1997-05-22
HU914153D0 (en) 1992-03-30
EP0494071A3 (en) 1993-05-05
KR920011988A (ko) 1992-07-25
CN1040003C (zh) 1998-09-30
NO309274B1 (no) 2001-01-08
SG50457A1 (en) 1998-07-20
US5296591A (en) 1994-03-22
DE69218977T2 (de) 1997-08-07
FI915996A0 (fi) 1991-12-19
AU8985391A (en) 1992-07-02
JPH04297446A (ja) 1992-10-21
RU2073684C1 (ru) 1997-02-20
HU211943A9 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
KR100192991B1 (ko) 트리플루오로메틸케톤 유도체, 그것의 제법 및 용도
JP3847092B2 (ja) トロンビン抑制剤
RU2266901C2 (ru) 4-пиримидинил-n-ацил-l-фенилаланины и фармацевтическая композиция
JP4308263B2 (ja) γ−アミノ酪酸アナログの結晶形
EP0636141B1 (en) Pyrimidinyl acetamides as elastase inhibitors
US6469036B1 (en) Peptidyl heterocyclic ketones useful as tryptase inhibitors
AU7058600A (en) Cell adhesion inhibitors
JPH07505874A (ja) Ｈｌｅ阻害活性を有するラクタムペプチド
JPH05286946A (ja) 置換複素環式化合物
JP5892561B2 (ja) 統合失調症を治療し、薬物渇望を低減するためのシステイン及びシスチンのバイオ同配体
KR20010022405A (ko) Ｖｌａ-4에 의해 매개된 백혈구 유착을 억제하는설포닐화된 디펩타이드 화합물
AU2017249218B2 (en) Chiral peptides
US9133141B2 (en) Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
JP2003534233A (ja) ヒドロキサメート含有システインおよびセリンプロテアーゼ阻害剤
RU2017748C1 (ru) Производные нитратоалкановых кислот или их фармацевтически приемлемые соли
WO1991008199A1 (fr) Derive d'acide amine
EP0925786A1 (en) Remedies for ischemic diseases
EP2054402B1 (en) An aminoisoquinoline thrombin inhibitor with improved bioavailability
JPH08259532A (ja) ペプチド様化合物又はその薬理的に許容される塩
JPH07316056A (ja) エラスターゼ阻害用医薬組成物
JPWO1999032459A1 (ja) キマーゼ阻害剤
JPWO1998029118A1 (ja) 新規なトリペプチド化合物及び抗エイズ薬

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19911227

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19960205

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19911227

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19980915

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19981126

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19990201

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19990202

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20020123

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20030123

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20040120

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20050121

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20060126

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20070125

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20080122

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20090123

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20100129

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20110126

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20110126

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20121009

Termination category: Expiration of duration